Myasthenia gravis improvement in a patient receiving sunitinib for metastatic renal cell carcinoma
We present a case of a 59-year-old gentleman with myasthenia gravis and metastatic renal cell carcinoma that resolved on sunitinib. The clear temporal relationship between the patient receiving sunitinib for renal cell carcinoma and the resolution of his myasthenia gravis suggests that the improveme...
Gespeichert in:
| Veröffentlicht in: | Grand rounds 2010-01, Vol.10, p.42 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | 42 |
| container_title | Grand rounds |
| container_volume | 10 |
| creator | Lee, Jean S.Z Samman, Rateb Cockerell, Oliver C Fife, Kate Eisen, Tim |
| description | We present a case of a 59-year-old gentleman with myasthenia gravis and metastatic renal cell carcinoma that resolved on sunitinib. The clear temporal relationship between the patient receiving sunitinib for renal cell carcinoma and the resolution of his myasthenia gravis suggests that the improvement was due either to a paraneoplastic condition responding to treatment of the underlying malignancy or to a direct effect of sunitinib. Keywords Renal cell carcinoma; kidney cancer; myasthenia gravis; sunitinib. |
| doi_str_mv | 10.1102/1470-5206.2010.0008 |
| format | Article |
| fullrecord | <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A367301342</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A367301342</galeid><sourcerecordid>A367301342</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1172-5e695f3c7646bb1234340a6cc9f20d469a3857aa8b94a16c22b4bf73b8a3cbdc3</originalsourceid><addsrcrecordid>eNptjE1Lw0AQhhdRsFZ_gZcFz6mzH9kkx1L8gooXPZfZ6aaOJJuSjQX_vSuKeJCB-Xh45hXiUsFCKdDXylZQlBrcQkNmAFAfidkvPf6zn4qzlN4AjKrBzYR__MA0vYbIKHcjHjhJ7vfjcAh9iJPkKFHuceKvYwwU-MBxJ9N75Ikje9kOo-zDlDOyRFmJ2EkKXW44Esehx3Nx0mKXwsXPnIuX25vn1X2xfrp7WC3XBSlV6aIMrilbQ5WzznuljTUW0BE1rYatdQ2auqwQa99YVI609ta3lfE1GvJbMnNx9Z27wy5sOLbDNCL1nGizNK4yoIzV2Vr8Y-Xahp5piKHlzP88fALjXmg_</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Myasthenia gravis improvement in a patient receiving sunitinib for metastatic renal cell carcinoma</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Lee, Jean S.Z ; Samman, Rateb ; Cockerell, Oliver C ; Fife, Kate ; Eisen, Tim</creator><creatorcontrib>Lee, Jean S.Z ; Samman, Rateb ; Cockerell, Oliver C ; Fife, Kate ; Eisen, Tim</creatorcontrib><description>We present a case of a 59-year-old gentleman with myasthenia gravis and metastatic renal cell carcinoma that resolved on sunitinib. The clear temporal relationship between the patient receiving sunitinib for renal cell carcinoma and the resolution of his myasthenia gravis suggests that the improvement was due either to a paraneoplastic condition responding to treatment of the underlying malignancy or to a direct effect of sunitinib. Keywords Renal cell carcinoma; kidney cancer; myasthenia gravis; sunitinib.</description><identifier>ISSN: 1470-5206</identifier><identifier>EISSN: 1470-5206</identifier><identifier>DOI: 10.1102/1470-5206.2010.0008</identifier><language>eng</language><publisher>E-Med Ltd</publisher><subject>Antimitotic agents ; Antineoplastic agents ; Carcinoma, Renal cell ; Metastasis ; Myasthenia gravis</subject><ispartof>Grand rounds, 2010-01, Vol.10, p.42</ispartof><rights>COPYRIGHT 2010 E-Med Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1172-5e695f3c7646bb1234340a6cc9f20d469a3857aa8b94a16c22b4bf73b8a3cbdc3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27928,27929</link.rule.ids></links><search><creatorcontrib>Lee, Jean S.Z</creatorcontrib><creatorcontrib>Samman, Rateb</creatorcontrib><creatorcontrib>Cockerell, Oliver C</creatorcontrib><creatorcontrib>Fife, Kate</creatorcontrib><creatorcontrib>Eisen, Tim</creatorcontrib><title>Myasthenia gravis improvement in a patient receiving sunitinib for metastatic renal cell carcinoma</title><title>Grand rounds</title><description>We present a case of a 59-year-old gentleman with myasthenia gravis and metastatic renal cell carcinoma that resolved on sunitinib. The clear temporal relationship between the patient receiving sunitinib for renal cell carcinoma and the resolution of his myasthenia gravis suggests that the improvement was due either to a paraneoplastic condition responding to treatment of the underlying malignancy or to a direct effect of sunitinib. Keywords Renal cell carcinoma; kidney cancer; myasthenia gravis; sunitinib.</description><subject>Antimitotic agents</subject><subject>Antineoplastic agents</subject><subject>Carcinoma, Renal cell</subject><subject>Metastasis</subject><subject>Myasthenia gravis</subject><issn>1470-5206</issn><issn>1470-5206</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptjE1Lw0AQhhdRsFZ_gZcFz6mzH9kkx1L8gooXPZfZ6aaOJJuSjQX_vSuKeJCB-Xh45hXiUsFCKdDXylZQlBrcQkNmAFAfidkvPf6zn4qzlN4AjKrBzYR__MA0vYbIKHcjHjhJ7vfjcAh9iJPkKFHuceKvYwwU-MBxJ9N75Ikje9kOo-zDlDOyRFmJ2EkKXW44Esehx3Nx0mKXwsXPnIuX25vn1X2xfrp7WC3XBSlV6aIMrilbQ5WzznuljTUW0BE1rYatdQ2auqwQa99YVI609ta3lfE1GvJbMnNx9Z27wy5sOLbDNCL1nGizNK4yoIzV2Vr8Y-Xahp5piKHlzP88fALjXmg_</recordid><startdate>20100101</startdate><enddate>20100101</enddate><creator>Lee, Jean S.Z</creator><creator>Samman, Rateb</creator><creator>Cockerell, Oliver C</creator><creator>Fife, Kate</creator><creator>Eisen, Tim</creator><general>E-Med Ltd</general><scope/></search><sort><creationdate>20100101</creationdate><title>Myasthenia gravis improvement in a patient receiving sunitinib for metastatic renal cell carcinoma</title><author>Lee, Jean S.Z ; Samman, Rateb ; Cockerell, Oliver C ; Fife, Kate ; Eisen, Tim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1172-5e695f3c7646bb1234340a6cc9f20d469a3857aa8b94a16c22b4bf73b8a3cbdc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Antimitotic agents</topic><topic>Antineoplastic agents</topic><topic>Carcinoma, Renal cell</topic><topic>Metastasis</topic><topic>Myasthenia gravis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Jean S.Z</creatorcontrib><creatorcontrib>Samman, Rateb</creatorcontrib><creatorcontrib>Cockerell, Oliver C</creatorcontrib><creatorcontrib>Fife, Kate</creatorcontrib><creatorcontrib>Eisen, Tim</creatorcontrib><jtitle>Grand rounds</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Jean S.Z</au><au>Samman, Rateb</au><au>Cockerell, Oliver C</au><au>Fife, Kate</au><au>Eisen, Tim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Myasthenia gravis improvement in a patient receiving sunitinib for metastatic renal cell carcinoma</atitle><jtitle>Grand rounds</jtitle><date>2010-01-01</date><risdate>2010</risdate><volume>10</volume><spage>42</spage><pages>42-</pages><issn>1470-5206</issn><eissn>1470-5206</eissn><abstract>We present a case of a 59-year-old gentleman with myasthenia gravis and metastatic renal cell carcinoma that resolved on sunitinib. The clear temporal relationship between the patient receiving sunitinib for renal cell carcinoma and the resolution of his myasthenia gravis suggests that the improvement was due either to a paraneoplastic condition responding to treatment of the underlying malignancy or to a direct effect of sunitinib. Keywords Renal cell carcinoma; kidney cancer; myasthenia gravis; sunitinib.</abstract><pub>E-Med Ltd</pub><doi>10.1102/1470-5206.2010.0008</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1470-5206 |
| ispartof | Grand rounds, 2010-01, Vol.10, p.42 |
| issn | 1470-5206 1470-5206 |
| language | eng |
| recordid | cdi_gale_infotracmisc_A367301342 |
| source | EZB-FREE-00999 freely available EZB journals |
| subjects | Antimitotic agents Antineoplastic agents Carcinoma, Renal cell Metastasis Myasthenia gravis |
| title | Myasthenia gravis improvement in a patient receiving sunitinib for metastatic renal cell carcinoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T07%3A56%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Myasthenia%20gravis%20improvement%20in%20a%20patient%20receiving%20sunitinib%20for%20metastatic%20renal%20cell%20carcinoma&rft.jtitle=Grand%20rounds&rft.au=Lee,%20Jean%20S.Z&rft.date=2010-01-01&rft.volume=10&rft.spage=42&rft.pages=42-&rft.issn=1470-5206&rft.eissn=1470-5206&rft_id=info:doi/10.1102/1470-5206.2010.0008&rft_dat=%3Cgale%3EA367301342%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A367301342&rfr_iscdi=true |